US 10273299
Antibodies to tumor endothelial marker 8
granted A61KA61K39/39558A61K45/06
Quick answer
US patent 10273299 (Antibodies to tumor endothelial marker 8) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K39/39558, A61K45/06, A61K47/6809, A61K47/6811